- Home
- CSBR vs OPAD Comparison
CSBR vs OPAD Comparison
Compare CSBR & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- OPAD
- Stock Information
- Founded
- CSBR 1985
- OPAD 2015
- Country
- CSBR United States
- OPAD United States
- Employees
- CSBR N/A
- OPAD N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- OPAD Real Estate
- Sector
- CSBR Health Care
- OPAD Finance
- Exchange
- CSBR Nasdaq
- OPAD Nasdaq
- Market Cap
- CSBR 90.0M
- OPAD 89.3M
- IPO Year
- CSBR 1986
- OPAD N/A
- Fundamental
- Price
- CSBR $6.75
- OPAD $1.70
- Analyst Decision
- CSBR Strong Buy
- OPAD Hold
- Analyst Count
- CSBR 1
- OPAD 4
- Target Price
- CSBR $12.00
- OPAD $2.22
- AVG Volume (30 Days)
- CSBR 11.7K
- OPAD 2.0M
- Earning Date
- CSBR 12-10-2025
- OPAD 11-03-2025
- Dividend Yield
- CSBR N/A
- OPAD N/A
- EPS Growth
- CSBR N/A
- OPAD N/A
- EPS
- CSBR 0.21
- OPAD N/A
- Revenue
- CSBR $56,878,000.00
- OPAD $627,966,000.00
- Revenue This Year
- CSBR $7.31
- OPAD N/A
- Revenue Next Year
- CSBR $12.01
- OPAD $31.90
- P/E Ratio
- CSBR $31.73
- OPAD N/A
- Revenue Growth
- CSBR 10.11
- OPAD N/A
- 52 Week Low
- CSBR $4.07
- OPAD $0.91
- 52 Week High
- CSBR $11.99
- OPAD $6.35
- Technical
- Relative Strength Index (RSI)
- CSBR 51.74
- OPAD 28.23
- Support Level
- CSBR $6.65
- OPAD $1.67
- Resistance Level
- CSBR $6.87
- OPAD $2.98
- Average True Range (ATR)
- CSBR 0.16
- OPAD 0.22
- MACD
- CSBR 0.01
- OPAD -0.07
- Stochastic Oscillator
- CSBR 54.55
- OPAD 4.44
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.